• 1. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 2. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 3. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 4. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 5. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851

(dimethyl-1,3-oxazol-2-yl)methanol and CAS No. 709674-68-0: A Comprehensive Overview in Modern Chemical Research

(dimethyl-1,3-oxazol-2-yl)methanol, identified by the CAS number 709674-68-0, is a compound of significant interest in the field of organic chemistry and pharmaceutical research. This heterocyclic alcohol has garnered attention due to its unique structural properties and potential applications in drug development, particularly in the synthesis of bioactive molecules. The compound features a 1,3-oxazole ring system substituted with two methyl groups at the 1 and 3 positions, linked to a hydroxymethyl group at the 2 position. This specific arrangement imparts distinct chemical reactivity and makes it a valuable building block for medicinal chemists.

The< strong>1,3-oxazole core is a well-known scaffold in medicinal chemistry, renowned for its ability to participate in various hydrogen bonding interactions and its stability under a range of chemical conditions. These characteristics make it an attractive moiety for designing molecules with enhanced binding affinity and selectivity towards biological targets. In recent years, there has been growing interest in incorporating oxazole derivatives into drug candidates due to their demonstrated efficacy in modulating enzyme activity and receptor binding. The presence of the< strong>methyl groups at the 1 and 3 positions of the oxazole ring further influences the electronic distribution and steric environment of the molecule, allowing for fine-tuning of its pharmacological properties.

CAS No. 709674-68-0 specifically refers to< strong>(dimethyl-1,3-oxazol-2-yl)methanol, a compound that has been explored in several cutting-edge research projects aimed at developing novel therapeutic agents. One notable area of investigation involves the use of this compound as a precursor in the synthesis of kinase inhibitors. Kinases are enzymes that play crucial roles in cell signaling pathways, and their dysregulation is implicated in numerous diseases, including cancer. By designing molecules that selectively inhibit specific kinases, researchers aim to develop treatments that can modulate these pathways effectively.

Recent studies have highlighted the potential of< strong>(dimethyl-1,3-oxazol-2-yl)methanol as a key intermediate in the preparation of small-molecule inhibitors targeting protein-protein interactions. These interactions are essential for many biological processes, and their disruption can lead to therapeutic benefits. The< strong>hydroxymethyl group at the 2 position of the oxazole ring provides a versatile handle for further functionalization, enabling chemists to attach various pharmacophores that enhance binding affinity and reduce off-target effects. This flexibility has made< strong>CAS No. 709674-68-0 a valuable reagent in synthetic chemistry laboratories.

In addition to its role in kinase inhibition studies, (dimethyl-1,3-oxazol-2-yl)methanol has been investigated for its potential applications in materials science. The unique electronic properties of the oxazole ring make it an interesting candidate for designing organic semiconductors and luminescent materials. These materials are used in various technological applications, including organic light-emitting diodes (OLEDs) and photovoltaic devices. The incorporation of< strong>methyl groups into the oxazole framework can influence the electronic characteristics of these materials, leading to improved performance and stability.

The synthesis of< strong>(dimethyl-1,3-oxazol-2-yl)methanol involves multi-step organic transformations that highlight its synthetic utility. Researchers have developed efficient synthetic routes that leverage catalytic methods to construct the oxazole core with high regioselectivity. These methods often involve cyclization reactions between appropriate precursors under controlled conditions, ensuring minimal side products and high yields. The ability to produce< strong>CAS No. 709674-68-0 in good yields has been instrumental in advancing its applications across different fields.

The pharmacological potential of< strong>(dimethyl-1,3-oxazol-2-yl)methanol has also been explored in preclinical studies aimed at identifying novel drug candidates for neurological disorders. The oxazole scaffold is known to interact with various neurotransmitter receptors, making it a promising candidate for developing treatments for conditions such as Alzheimer's disease and Parkinson's disease. The< strong>methyl groups on the oxazole ring can be modified to optimize binding interactions with specific receptor subtypes, potentially leading to more targeted therapies.

In conclusion,< strong>(dimethyl-1,3-oxazol-2-ylmethanol

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)